Antibody molecules having specificity for human OX40

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9428570
APP PUB NO 20130330344A1
SERIAL NO

13973189

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to antibody molecules having specificity for antigenic determinants of human OX40, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UCB BIOPHARMA SPRL60 ALLEE DE LA RECHERCHE BRUSSELS B-1070

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lawson, Alastair David Griffiths Slough, GB 48 824
Nesbitt, Andrew Malcolm Slough, GB 3 79
Popplewell, Andrew George Slough, GB 51 543
Shaw, Stevan Graham Slough, GB 10 92
Shpektor, Diana Shoreline, US 4 158
Zhang, Yi San Francisco, US 1568 13461

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 29, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 29, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00